Key result
The combination of pravastatin and pioglitazone markedly inhibited ANG II-induced oxidative stress, MAPK activation, and procollagen-1 expression in mouse cardiac fibroblasts.
Why the study?
Does the combination of pravastatin and pioglitazone reduce ANG II-mediated oxidative stress and procollagen-1 expression in mouse cardiac fibroblasts?
Population
Mouse cardiac fibroblasts treated with Angiotensin II (ANG II)
Comparison
Combination of pravastatin and pioglitazone vs Pravastatin alone, pioglitazone alone, or no…
Design
Preclinical
Authors
Loading...
Should not change clinical practice; hypothesis-generating for combined statin-PPARγ effects on ANG II-driven cardiac fibrosis.
Does the combination of pravastatin and pioglitazone reduce ANG II-mediated oxidative stress and procollagen-1 expression in mouse cardiac fibroblasts?
The combination of pravastatin and pioglitazone synergistically inhibits ANG II-mediated oxidative stress and procollagen-1 expression in mouse cardiac fibroblasts, suggesting a potential antifibrotic mechanism.
Chen et al. (2006) studied ANG II-treated mouse cardiac fibroblasts. Combination of pravastatin and pioglitazone vs. ANG II alone or individual treatments was evaluated on procollagen-1 expression, NADPH oxidase expression, superoxide anion production, and MAPK activation. The combination of pravastatin and pioglitazone markedly inhibited ANG II-induced oxidative stress, MAPK activation, and procollagen-1 expression in mouse cardiac fibroblasts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: